Genmab — November 2022

[JKY_VH]

"Udnyttelseskursen for hver warrant er 3.172 kr. Hver tegningsoption tildeles omkostningsfrit og giver ejeren ret til at tegne én aktie á nominelt DKK 1 mod betaling af udnyttelseskursen. Ved anvendelse af Black-Scholes-formlen kan dagsværdien af hver warrant opgøres til DKK 1.123,15." og god morgen

[JKY_VH]

Ja, de kommer fra julemanden

[bikube]

MarketWire kan ikke regne. 7x189, og Deidre får dobbelt, Pernille får +50%, det er 10,5x189=1985. Deskriver 1309. Det er aktier, der uddeles af egne aktier, hvorimod Warrats hidtil er dækket med nyudstedte aktier.

[gentogen]

On June 17, 2022 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program.

[gentogen]

De købte 370.000 i sommers

[E_L]

GSK to pull US marketing authorisation for multiple myeloma therapy Blenrep https://firstwordpharma.com/story/5678499

[Sukkeralf]

Probably makes it a bit more easy for Tecvayli - but lower than expected efficacy and the ocular tox for Blenrep did´nt make it a huge product anyway

[Sukkeralf]

BMS/Sutro has a BCMA ADC on the way - Sutro delivers the technology and BMS runs the clinical trials. But we havent seen any data jet and its been in the clinic since 2019 if I remember correctly. But Sutro talks very positive about it - and at least its does not have issues with ocular tox.

[Helge_LarsenPI-redaktør]

Godmorgen

[Stroka]

God morgen

[ProinvestorNEWS]

Onsdagens aviser med Novo Nordisk, SAS og Danish Crown https://www.proinvestor.com/investornyt/908002/onsdagens-aviser-med-novo-nordisk-sas-og-danish-crown

[E_L]

a bit more on Belantamab withdrawal from market https://twitter.com/VincentRK/status/1595227701899657216

[ProinvestorNEWS]

Aktier/tendens: Rockwool og Sydbank i fokus på ventet grøn start https://www.proinvestor.com/investornyt/908016/aktier-tendens-rockwool-og-sydbank-i-fokus-pa-ventet-gron-start

[Darvin]

Overskrift: AbbVie Highlights blood cancer data og epcoritamab/Genmab på
American Society of Hemaotology (ASH) annual congress

[E_L]

hmmm, i count 17 for epco versus 14 in the genmab press release

[Darvin]

Yes and they mention OR highligth Epco frist, both at the top and in the bottom of their PR. look’s good and promising

[E_L]

surely Genmab should get one of these hologram displays into their office
entrances https://virtualongroup.com/portfolio-items/interactive-holographic-display-marriott-conference-center-madrid/

[Sukkeralf]

https://firstwordpharma.com/story/5679170

[E_L]

that is a bit surprising , no? they had a similar agreement with halozyme, funny thing is it was signed EXACTLY 2 yrs ago lol https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-and-halozyme-therapeutics-inc-enter

[bikube]

Så solgte Judih lige 900 aktier, det er ikke meget at sende en børsmeddelelse om,, men det skal de jo.